---
title: "Neurocrine Biosciences (NBIX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NBIX.US/norm.md"
symbol: "NBIX.US"
name: "Neurocrine Biosciences"
parent: "https://longbridge.com/en/quote/NBIX.US.md"
datetime: "2026-05-21T05:30:03.506Z"
locales:
  - [en](https://longbridge.com/en/quote/NBIX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NBIX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NBIX.US/norm.md)
---

# Neurocrine Biosciences (NBIX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 1.91 | 1.48 | 2.04 | 1.06 | 0.0792 |
| ROE | 23.77% | 19.65% | 29.41% | 16.44% | 1.23% |
| Revenue | 814.50M | 805.50M | 794.90M | 687.50M | 572.60M |
| Net income | 197.90M | 153.70M | 209.50M | 107.50M | 7.90M |
| Operating income | 186.00M | 227.20M | 239.30M | 145.60M | 23.70M |
| Gross margin | 61.94% | 65.76% | 66.79% | 62.82% | 52.43% |
| Net margin | 24.30% | 19.08% | 26.36% | 15.64% | 1.38% |
| Profit quality | 127.57% | 58.50% | 105.19% | 142.75% | 36.57% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 4.91B | 4.63B | 4.27B | 3.89B | 3.69B |
| Leverage | 1.44 | 1.42 | 1.42 | 1.44 | 1.45 |
| BVPS | 33.87 | 32.50 | 30.13 | 27.22 | 25.61 |
| Turnover | 0.7220 | 0.6851 | 0.6878 | 0.6977 | 0.6739 |
| Cash & STI | 1.32B | 1.48B | 1.11B | 975.60M | 943.50M |
| Inv & Rec | 64.50M | 69.00M | 69.30M | 56.90M | 59.10M |
| LT assets | 538.00M | 545.20M | 566.20M | 584.00M | 589.20M |
| Net debt | -852.70M | -1.01B | -635.10M | -485.80M | -450.40M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 145.80M | 388.40M | 227.50M | 102.00M | 64.80M |
| Investing CF | -506.20M | -52.90M | -196.70M | -29.00M | 14.20M |
| Financing CF | -86.10M | 37.30M | 45.60M | -3.30M | -117.90M |
| Free CF | 181.05M | 312.50M | -35.14M | 25.20M | -11.69M |
| OCF coverage | 1602.20% | -16183.33% | 1723.48% | 816.00% | 605.61% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -9.10M | 2.40M | -13.20M | -12.50M | -10.70M |